Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Race For The Next Blockbuster Schizophrenia Drug
Seeking Alpha
Thursday, July 19, 2012 - 8:39am
tags:
schizophrenia, Eli Lilly, Addex, BioLineRx, Lundbeck, Targacept
ImmunoCellular Therapeutics Will Benefit As FDA Speeds Up Approval Process
Seeking Alpha
Thursday, July 19, 2012 - 7:47am
tags:
ImmunoCellular Therapeutics, drug approvals, FDA, Celldex, Dendreon, Jazz Pharmaceuticals, Questcor, Sunesis, Threshold Pharmaceuticals, Spectrum Pharmaceuticals
Actelion Raises 2012 Forecast On Reduced First-Half Costs
Bloomberg
Thursday, July 19, 2012 - 7:45am
tags:
Actelion, guidance
Taro Pharmaceutical announces rejection of Sun Pharma's proposal
The Fly on the Wall
Thursday, July 19, 2012 - 7:43am
tags:
Sun Pharma, Taro
FDA Approves New Gilead Medication for HIV Prevention Study
WSJ Online
Thursday, July 19, 2012 - 7:41am
tags:
FDA, HIV, Gilead, Truvada
Drug maker Novartis reports Q2 net profit of $2.7B
Yahoo/AP
Thursday, July 19, 2012 - 7:38am
tags:
Novartis, earnings
AstraZeneca backs $12M round for upstart's self-assembling drug pipeline
Fierce Biotech
Wednesday, July 18, 2012 - 12:59pm
tags:
AstraZeneca, MedImmune Ventures, Ascent Biomedical Ventures
5 Analyst-Backed Healthcare Small Caps Commanding Strong Profits
Seeking Alpha
Wednesday, July 18, 2012 - 12:57pm
tags:
Questcor, Trinity Biotech, Immunomedics, BioSpecifics Technologies, Mesa Labs
J&J ramping up OTC production as 'decree' work allows
Fierce Pharma
Wednesday, July 18, 2012 - 12:55pm
tags:
OTC, JNJ
New EnVivo drug for Alzheimer's symptom relief shows promise
Reuters
Wednesday, July 18, 2012 - 12:54pm
tags:
EnVivo, Alzheimer's disease, EVP-6124
Amag to pitch anemia drug for wider indication
Reuters
Wednesday, July 18, 2012 - 12:37pm
tags:
anemia, Amag Pharmaceuticals, Feraheme
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wednesday, July 18, 2012 - 12:27pm
tags:
Pluristem Therapeutics, Alkermes, AstraZeneca, Bristol-Myers Squibb, Isis Pharmaceuticals, Eli Lilly, Momenta, Merck, Pfizer, Sanofi, Spectrum Pharmaceuticals
Dealtalk: Surge in biotech deals to unlock big investor profits
Reuters
Wednesday, July 18, 2012 - 12:16pm
tags:
M&A, GSK, Human Genome Sciences
Qnexa (Now Qsymia) Granted FDA Approval, Now What?
Seeking Alpha
Wednesday, July 18, 2012 - 12:15pm
tags:
Qnexa, FDA, Vivus, obesity, Qsymia
Vivus Stock Jumps 12.5% On Drug Approval
Investors.com
Wednesday, July 18, 2012 - 12:14pm
tags:
Vivus, approval, Qnexa, Qsymia, obesity
InterMune Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Wednesday, July 18, 2012 - 12:13pm
tags:
earnings, InterMune
No Tears For Johnson & Johnson, Still Remarkable
Seeking Alpha
Wednesday, July 18, 2012 - 12:10pm
tags:
JNJ, earnings
Novo faces new hurdle in long-acting insulin race
Reuters
Wednesday, July 18, 2012 - 11:52am
tags:
Novo Nordisk, degludec, long-acting insulin
Abbott Labs net declines; year outlook affirmed
Marketwatch
Wednesday, July 18, 2012 - 10:59am
tags:
Abbott Laboratories, earnings
U.S. FDA approves Vivus weight-loss pill Qsymia
Reuters
Tuesday, July 17, 2012 - 10:31pm
tags:
FDA, obesity, Vivus, Qsymia, Qnexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.